Quantitative Subanalysis of Optical Coherence Tomography after Treatment with Ranibizumab for Neovascular Age-Related Macular Degeneration
Author(s) -
Pearse A. Keane,
Sandra Liakopoulos,
Sharel Ongchin,
Florian M. Heussen,
Sandeep Msutta,
Karen T. Chang,
Alexander C. Walsh,
Srinivas R. Sadda
Publication year - 2008
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.08-1689
Subject(s) - medicine , macular degeneration , ranibizumab , ophthalmology , optical coherence tomography , retinal , retina , reduction (mathematics) , surgery , bevacizumab , optics , physics , geometry , mathematics , chemotherapy
To investigate the effects of ranibizumab on retinal morphology in patients with neovascular age-related macular degeneration (AMD) using optical coherence tomography (OCT) quantitative subanalysis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom